Herrera-Villalobos JE, Sil JPA, Pinal GFM, Garduño AA, Santamaría BAM, Rueda VJP

Language: Spanish
References: 17
Page: 261-265
PDF size: 98.78 Kb.

ABSTRACT

Introduction and objective: Pregnancy-induced hypertension or preeclampsia presents pathophysiological features similar to atherosclerosis and cardiovascular disease. Identifing atherogenic risk factors and their relationship in preeclampsia was the purpose of this study. Method: We conducted a cross-sectional descriptive research, with 50 patients in the third trimester of pregnancy. Weight and height, to calculate body mass index, were established through the interview. Blood pressure › 140/90 mmHg accompanied by edema and proteinuria in pregnancy, was classified as hypertension. Blood samples were taken to determine the values of serum cholesterol, triglyceride and HDL. The variables are expressed as percentages. Results: The number of risk factors and their associations were analyzed in each patient. The most important result was that 76% were overweight or obese. The preeclampsia syndrome, was found in 30% of patients with a relative risk of 3 times the normal lipid profile, and 30% had a high atherogenic index. Conclusions: Dyslipidemia is an important atherogenic risk factor, together constitute a risk factor for preeclampsia. The increment of atherogenic index increases susceptibility to atherogenesis in preeclampsia. Dyslipidemia appears to be the starting point of these subsequent events. The study of the role of dyslipidemia could contribute to the understanding of the mechanisms of endothelial dysfunction in preeclampsia.

REFERENCES

1. Leis Márquez MT, Rodríguez Bosch MR, García Ló-pez MA. Diagnóstico y tratamiento de la preeclamp-sia-eclampsia. Ginecol Obstet Méx. 2010;78(6):461-525.

2. Morgan-Ortiz F, Calderón-Lara SA, Martínez-Félix JI, González- Beltrán A, Quevedo-Castro E. Facto-res de riesgo asociados con preeclampsia: estudio de casos y controles. Ginecol Obstet Méx. 2010; 78(3):153-9.

3. Peralta-Padrero ML, Guzmán MA, Basavilvazo MA, Sánchez S, Cruz A, Lemus R, et al. Elaboración y validación de un índice para el diagnóstico de pre-eclampsia. Ginecol Obstet Méx. 2006;74(4):205-14.

4. Pacheco Romero J. Disfunción endotelial en la pre-eclampsia. An Fac Med. 2003;64(1):43-54.

5. Var A, Kuşcu NK, Koyuncu F, Uyanik BS, Onur E, Yildirim Y, et al. Atherogenic profile in preeclamp-sia. Arch Gynecol Obstet. 2003;268(1):45-7.

6. Herrera JE, Sil PA, Camacho IR, Villagrán VM, Pi-nal FM, Flores OM, et al. Determinación de niveles plasmáticos de enzimas cardiacas en síndrome de preeclampsia-eclampsia. Arch Inv Mat Inf. 2011; III(1):15-8.

7. Bayhan G, Kocyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol En-docrinol. 2005;21(1):1-6.

8. Ray JG, Diamond P, Singh G, Bell CM. Brief over-view of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006;113(4):379-86.

9. Iftikhar U, Iqbal A, Shakoor S. Relationship between leptin and lipids during pre-eclampsia. J Pak Med Assoc. 2010;60(6):432-5.

10. Duley L, Meher S, Abalos E. Management of pre-eclampsia. BMJ. 2006;332:463-8.

11. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-99.

12. Reyna-Villasmil E, Briceño-Pérez C, Torres-Cepe-da D. Marcadores bioquímicos para la predicción de la preeclampsia. Rev Obstet Ginecol Venez. 2010; 70(1):53-66.

13. Iftikhar U, Khoja A, Iqbal A, Karira KA. Evaluation of serum leptin levels during normal pregnancy and in pre-eclampsia. J Ayub Med Coll Abbottabad. 2008; 20(4):137-40.

14. Nava P, Garduño A, Pestaña S, Santamaría M, Vázquez G, Camacho R, Herrera J. Obesidad pre- gestacional y riesgo de intolerancia a la glucosa en el embarazo y diabetes gestacional. Rev Chil Obstet Ginecol. 2011;76(1):10-4.

15. Chambers JC, Fusi L, Malik IS, Haskard Do, De Swiet M, Kooner JS. Association of maternal endo-thelial dysfunction with preeclampsia. JAMA. 2001; 285(12):1607-12.

16. Adali E, Yildizhan R, Kolusari A, Kurdoglu M, Bug-dayci G, Sahin HG, et al. Increased visfatin and lep-tin in pregnancies complicated by pre-eclampsia. J Matern Fetal Neonatal Med. 2009;22(10):873-9.

17. Herrera-Villalobos JE, Garay SG, Adaya LE, Cama-cho BR, Garduño AA, Nava PM. Riesgo de dislipi-demia en pacientes que han sufrido preeclampsia. Arch Inv Mat Inf. 2010:2(2):67-70.